Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Apr 12, 2026
Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom).
Read at PubMed CentralPubMed Central · Apr 10, 2026
The Predictive Value of the Tumor-Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer.
Read at PubMed CentralPubMed Central · Apr 9, 2026
At what age should people with obesity start colorectal cancer screening?
Read at PubMed CentralPubMed Central · Apr 9, 2026
Effect of Interval Between Neoadjuvant Immunochemotherapy and Radical Resection of Non-Small Cell Lung Cancer: A Multicenter, Retrospective Cohort Study.
Read at PubMed CentralPubMed Central · Apr 9, 2026
Perioperative outcomes following open radical cystectomy in the setting of locally advanced bladder cancer.
Read at PubMed CentralPubMed Central · Apr 8, 2026
Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review.
Read at PubMed CentralPubMed Central · Apr 1, 2026
Globo-H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancer.
Read at PubMed CentralPubMed Central · Mar 30, 2026
Identifying gene expression signatures for risk stratification of postoperative adjuvant chemotherapy in colorectal cancer.
Read at PubMed CentralPubMed Central · Mar 27, 2026
Mass-forming Acellular Keratin Masquerading as "Residual Tumor" in a Metaplastic Breast Carcinoma with Pathologic Complete Response: A Case Report.
Read at PubMed CentralPubMed Central · Mar 26, 2026
Work accommodations described by a racially and socioeconomically diverse sample of women undergoing treatment for breast cancer.
Read at PubMed CentralPubMed Central · Mar 26, 2026
Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.
Read at PubMed CentralNational Cancer Institute · Mar 25, 2026
Chronic inflammation leaves long-lasting impression on gut stem cells, increasing colorectal cancer risk
In a new study, funded in part by the National Institutes of Health (NIH), researchers have uncovered a molecular mechanism that could explain how chronic gut inflammation may increase the risk of colorectal cancer. By simulating chronic colitis in mice and tracking the colon’s response during inflammation and recovery, scientists demonstrated that these changes increased the activity of a specific group of proteins, AP-1 transcription factors, and promoted tumor growth.
View original at National Cancer InstitutePubMed Central · Mar 21, 2026
Salvage Metastasectomy After Adoptive Cell Transfer for Melanoma: Long-Term Updates.
Read at PubMed CentralPubMed Central · Mar 16, 2026
Comparative Evaluation of Four Stereotactic Radiosurgery Planning Approaches for Treatment of Posterior Choroidal Melanoma.
Read at PubMed CentralPubMed Central · Mar 16, 2026
The prognostic value of methylated ctDNA, soluble PD-L1, and NK-cell activity on the risk of relapse after curative radiotherapy of non-small cell lung cancer.
Read at PubMed CentralPubMed Central · Mar 13, 2026
The MTH1 inhibitor TH287 sensitized Castration-Resistant Prostate Cancer cells to ionizing radiation therapy.
Read at PubMed CentralPubMed Central · Mar 12, 2026
Stated Preferences for Systemic Treatments for Prostate Cancer: A Targeted Review of the Discrete-Choice Experiment Literature.
Read at PubMed CentralPubMed Central · Mar 12, 2026
Clinical experience and satisfaction in patients with advanced breast cancer participating in the abemaciclib patient support program in Spain: a prospective observational study.
Read at PubMed CentralPubMed Central · Mar 11, 2026
Incorporating the Patient Voice into Attribute and Level Selection for a Preference Study: A Qualitative Study in Non-Muscle Invasive Bladder Cancer.
Read at PubMed CentralPubMed Central · Mar 9, 2026
Evaluation of T1 and T2 mapping for non-invasive assessment of HER2 and PD-L1 expression in bladder cancer.
Read at PubMed Central